<DOC>
	<DOCNO>NCT00950547</DOCNO>
	<brief_summary>PURPOSE : Autotransfusion device may employ cardiac surgery decrease allogenic blood requirement . Limitations previous trial include use cell saver system select high risk patient lack blood transfusion-sparing strategy . The aim prospective randomize study evaluate efficacy cell salvage CardioPAT routinely use cardiac surgery . METHODS : The investigator randomize 350 patient two group : group 1 receive CardioPAT cell saver device ( 175 patient ) , group 2 n't receive cell saver device . The incidence allogenic blood transfusion clinical outcome group evaluate .</brief_summary>
	<brief_title>ICU Cell Saver Reduce Blood Transfusions Cardiac</brief_title>
	<detailed_description />
	<criteria>All patient present cardiac Surgery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Blood Transfusion</keyword>
	<keyword>Cell Saver</keyword>
	<keyword>Cardiac Surgery</keyword>
	<keyword>Evaluate efficacy cell salvage CardioPAT routinely use cardiac surgery reduce blood transfusion .</keyword>
</DOC>